APA

Qiu S., van Rooijen J., Nienhuis H. H., van der Vegt B., Timmer-Bosscha H., van Leeuwen-Stok E., Walenkamp A. M. E., van Deurzen C. H. M., de Bock G. H., de Vries E. G. E. & Schröder C. P. (20201001). High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer. : Breast cancer research : BCR.

Chicago

Qiu Si-Qi, van Rooijen Johan, Nienhuis Hilde H, van der Vegt Bert, Timmer-Bosscha Hetty, van Leeuwen-Stok Elise, Walenkamp Annemiek M E, van Deurzen Carolien H M, de Bock Geertruida H, de Vries Elisabeth G E and Schröder Carolien P. 20201001. High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer. : Breast cancer research : BCR.

Harvard

Qiu S., van Rooijen J., Nienhuis H. H., van der Vegt B., Timmer-Bosscha H., van Leeuwen-Stok E., Walenkamp A. M. E., van Deurzen C. H. M., de Bock G. H., de Vries E. G. E. and Schröder C. P. (20201001). High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer. : Breast cancer research : BCR.

MLA

Qiu Si-Qi, van Rooijen Johan, Nienhuis Hilde H, van der Vegt Bert, Timmer-Bosscha Hetty, van Leeuwen-Stok Elise, Walenkamp Annemiek M E, van Deurzen Carolien H M, de Bock Geertruida H, de Vries Elisabeth G E and Schröder Carolien P. High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer. : Breast cancer research : BCR. 20201001.